EGFR mutations were significantly more often observed in ADC than in SCC or other tumor types (10.6 %, 0 %, and 4.3 % respectively, p = 0.006) and more frequently in female than in male patients (13.4 % vs. 5.5 %, p < 0.001) (Table 1). Here, EGFR is linked to neoplasm.